The cyclic AMP system and drug development
Author:
- Charles G. SmithCSCharles G. Smith
- 31 December 1974
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 12, 187-203
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of Therapeutic Agents on Cyclic AMP Metabolism In VitroJournal of Pharmaceutical Sciences, 1972
- 1-ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)—a potent new inhibitor of cyclic 3′,5′-nucleotide phosphodiesterasesBiochemical Pharmacology, 1972
- Cyclic Adenosine Monophosphate Phosphodiesterase in Brain: Effect on AnxietyScience, 1972
- 1H‐pyrazolo[3,4‐b]pyridinesJournal of Heterocyclic Chemistry, 1972
- Cyclic AMP and AnxietyPsychosomatics, 1972
- A Quarter Century of Chemotherapy1969
- Cyclic AMP: Role of the medicinal chemistAdvances in Enzyme Regulation, 1968
- Cyclic AMPAnnual Review of Biochemistry, 1968
- Session I: Biochemistry and Metabolism: Effects of Alloplurnol in Relation to Purine BiosynthesisAnnals of the Rheumatic Diseases, 1966
- Chapter 24. Regulation of Cell Metabolism1966